Mygalin: A New Anticonvulsant Polyamine in Acute Seizure Model and Neuroethological Schedule

ISSN: 1875-6166 (Online)
ISSN: 1871-5249 (Print)


Volume 14, 2 Issues, 2014


Download PDF Flyer




Central Nervous System Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Gregory S. Hamilton
Eisai Inc.
Baltimore, MD
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Mygalin: A New Anticonvulsant Polyamine in Acute Seizure Model and Neuroethological Schedule

Author(s): Lívea Dornela Godoy, José Luiz Liberato, Pedro Ismael da Silva and Wagner Ferreira dos Santos

Affiliation: Av. Bandeirantes, 3900, FFCLRP/USP – Departamento de Biologia, Zip Code: 14040-901, Ribeirão Preto, São Paulo, Brazil.

Abstract

Polyamines are compounds that interact with ionotropic receptors, mainly modulating the NMDA receptor, which is strictly related to many neurologic diseases such as epilepsy. Consequently, polyamines rise as potential neuropharmacological tools in the prospection of new therapeutic drugs. In this paper, we report on the biological activity of synthetic polyamine Mygalin, which was tested as an anticonvulsant in model of chemically induced seizures. Male Wistar rats were injected with vehicle, diazepam, MK-801 or Mygalin at different doses followed by Pentylenetetrazole or N-Methyl-D-Aspartate administration. Mygalin presented protection against seizures induced by both NMDA injections and PTZ administration by 83.3% and 16.6%, respectively. Moreover, it prolonged the onset of tonic-clonic seizures induced by PTZ. Furthermore, it was tested in neuroethological schedule evaluating possible side-effects and it presented mild changes in Open Field, Rotarod and Morris Water Maze tests when compared to available anticonvulsant drugs. The mechanism underlying the anticonvulsant effect of Mygalin is noteworthy of further investigation, nevertheless, based on these findings, we hypothesize that it may be wholly or in part due to a possible NMDA receptor antagonism. Altogether, the results demonstrate that Mygalin has an anticonvulsant activity that may be an important tool in the study of prospection of therapeutics in epilepsy neuropharmacology.

Keywords: Anticonvulsant, MK-801, Morris Water Maze, Mygalin, NMDA, Open Field, polyamine, PTZ.

Purchase Online Rights and Permissions

  
  



Article Details

Volume: 13
Issue Number: 2
First Page: 122
Last Page: 131
Page Count: 10
DOI: 10.2174/18715249113139990015
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science